Euroapi SA EAPI
EURONEXT · France · Health Technology
€0.7330+0.01 (+1.24%)
Market closed· · EUR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · EUR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Euroapi is back in focus after analysts cut the official price target from €2.90 to €1.70, with fair value in the reference model shifting from €1.48 to €1.20. Recent commentary, including the latest move from JPMorgan to a €1.70 target, shows how the market is resetting its view of Euroapi to match updated expectations. Read on to see what this may indicate for you and how to track the next steps in the Euroapi story. Analyst Price Targets don't always capture the full story. Head over to...
Press Release Paris, 31 July 2026 Availability of 2026 Half-Year Financial Report EUROAPI posted today its 2026 condensed Half Year Consolidated Financial Statements for the six months ended June 30, 2026. This document is available for consultation and downloading on EUROAPI’s website: 2026 Half year results | EUROAPI This report includes notably the 2026 half-year management report, the consolidated financial statements on 30 June 2026, and the Statutory Auditors’ review report on the half-yea
Press Release Paris, 29th July 2026 €356.5 million Net Sales, down 13.5% year-on-year as reported and -11.8% on a comparative basis1 As expected, including a negative €13 million impact from the planned discontinuation of APIs resulting from the optimization of the product portfolio. Core EBITDA at €20.7 million (5.8% margin) compared to €39.5 million in H1 2025 (9.6% margin) Lower Sales and General Expenses, reflecting improved cost efficiency, partly offset by lower manufacturing activity EBIT
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.